A phase 1, randomized, controlled, observer-blinded, dose escalation study of the safety, tolerability and immunogenicity of a single dose of adjuvanted influenza vaccine combined with CpG7909 in healthy adults
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Agatolimod; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 11 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Nov 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 05 Nov 2009 Biomarkers information updated